Evidence map›Paper›PMID 33579767›Full record

ArticleBMJ open2021

Development and evaluation of a decision aid for family surrogate decision-makers for patients with acute kidney injury requiring renal replacement therapy (RRT) in ICUs: a study protocol.

Miao Zheng, Changlin Yin, Ying Cao, Yonghui Zhang, Kuoliang Zhang, Xiaoqin Zhang, Wei Bian, Lihua Wang

Abstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Miao ZhengGraduate School, Guizhou University of Traditional Chinese Medicine, Guiyang City, Guizhou Province, China.
Changlin YinDepartment of Critical Care Medicine, Southwest Hospital of Third Military Medical University (Amy Medical University), Chongqing, China.
Ying CaoDepartment of Critical Care Medicine, Southwest Hospital of Third Military Medical University (Amy Medical University), Chongqing, China.
Yonghui ZhangDepartment of Critical Care Medicine, Southwest Hospital of Third Military Medical University (Amy Medical University), Chongqing, China.
Kuoliang ZhangGraduate School, Guizhou University of Traditional Chinese Medicine, Guiyang City, Guizhou Province, China.
Xiaoqin ZhangGraduate School, Guizhou University of Traditional Chinese Medicine, Guiyang City, Guizhou Province, China.
Wei BianDepartment of Ophthalmology, Southwest Hospital of Third Military Medical University (Amy Medical University), Chongqing, China 773569612@qq.com 664091353@qq.com.
Lihua WangAddmin Office, Southwest Hospital of Third Military Medical University (Amy Medical University), Chongqing, China 773569612@qq.com 664091353@qq.com.ORCID 0000-0002-3053-4893

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionShared decision making is endorsed by guidelines for both acute kidney injury and critical care medicine. However, there is still a huge need for effective interventions, especially those focusing on decisions about renal replacement therapy for intensive care unit (ICU) patients with acute kidney injury. The decision aids provide evidence-based support for shared decision making, to achieve better decisions through enhanced knowledge of treatment options and treatment aligns with patients' preferences and values. Therefore, our objectives are to develop and evaluate a decision aid systematically and rigorously for family surrogate decision makers of ICU patients with acute kidney injury who need renal replacement therapy. METHODS AND ANALYSIS: We will use a systematic development process that focuses on user-centred design to develop and evaluate the decision aid in three phases: (1) development of a draft prototype for the decision aid based on extensive literature reviews, interviews with key stakeholders and evidence synthesis; (2) alpha testing ('near live' usability) the decision aid during simulated clinical encounters to test its comprehensibility, acceptability and usability and (3) beta testing ('live' usability) to examine the aid's clinical feasibility. User testing will be conducted using mixed-methods approach to support iterative revision of the decision aid. The IPDASi (V.4.0) will be used for following qualitative assessment. All interviews will be analysed by Colaizzi's seven-step approach to qualitative analysis. The coding scheme will use to analyse user interactions. Questionnaire surveys will be analysed using paired sample t-tests when related to the before-and-after survey, otherwise using one-sample t-test. ETHICS AND DISSEMINATION: Ethical approval for this research was obtained from the Ethics Committee of the First Affiliated Hospital of Army Medical University, PLA (Ref: KY2020104). All participants will sign a formal informed consent form. The findings will be published in peer-reviewed journals and reported in appropriate meetings. TRIAL REGISTRATION NUMBER: ChiCTR2000031613.

Indexed as

Acute Kidney InjuryIntensive Care UnitsDecision MakingDecision Support TechniquesHumansPatient PreferenceRenal Replacement Therapyacute renal failureadult intensive & critical carequalitative research

Identifiers

PMID33579767
PMCPMC7883861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.